For the Inventor, By the Inventor

Enter assignee name

Melbourne, Australia

Patrys Limited

USPTO Granted Patents = 10

% Expired Patents = 90.0

CIPO Patents = 1

EPO Patents = 7

Trademarks = 1

Forward Citations = 5

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Heinz Peter Vollmers (9 out of 12 patents)

Hans-Konrad Mueller-Hermelink (3 out of 3 patents)

Leodevico Luna Ilag (2 out of 6 patents)

4. Barbara E Power (2 out of 2 patents)

5. Frank Hensel (2 out of 3 patents)

6. Arndt-Rene Kelter (2 out of 2 patents)

7. Christopher Garth Hosking (2 out of 2 patents)

8. Hans-Konrad Müller-Hermelink (2 out of 2 patents)

9. Stephanie Ute Brandlein (1 out of 1 patent)

10. Andreas Thalheimer (1 out of 1 patent)

11. Lishanthi Udabage (1 out of 1 patent)

12. Frank Schoenen (1 out of 1 patent)

13. Hans-Konrad Müeller-Hermelink (1 out of 1 patent)

14. Hans Konrad Mueller-Hermelink (1 patent)

15. Heinz Vollmers (0 patent)

10 patents: Sort by Forward Citations

1. 9783599 - LM-antibodies, functional fragments, LM-1 target antigen, and methods for making and using same (2017-10-10),

2. 9273125 - Human monoclonal antibody having fat-reducing effect (2016-03-01),

3. 9265817 - PAT-LM1 epitopes and methods for using same (2016-02-23),

4. 8741296 - Adenocarcinoma specific antibody SAM-6, and uses thereof (2014-06-03),

5. 8562995 - Neoplasm specific antibodies and uses thereof (2013-10-22),

6. 8163552 - Adenocarcinoma specific antibody SAM-6, and uses thereof (2012-04-24),

7. 8124080 - Human monoclonal antibody having fat-reducing effect (2012-02-28),

8. 7947812 - Neoplasm specific antibodies and uses thereof (2011-05-24),

9. 7772372 - Neoplasm specific antibodies and uses thereof (2010-08-10),

10. 7741444 - Neoplasm specific antibodies and uses thereof (2010-06-22),

Patrys Limited is a biotechnology company based in Melbourne, Australia, specializing in the development of innovative therapies for cancer treatment. The company focuses on harnessing its proprietary technology platform to create monoclonal antibodies that target cancer cells, aiming to improve patient outcomes. Patrys is dedicated to advancing its research in the field of immunotherapy, with a commitment to addressing unmet medical needs in oncology through its cutting-edge scientific approaches.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

10 Patents

#34 in Melbourne

#390 in Australia

#55,986 in the World

Melbourne, Australia

Patrys Limited

Forward Citations = 5

13 inventors:

Heinz Peter Vollmers (9 out of 12 patents)

Hans-Konrad Mueller-Hermelink (3 out of 3 patents)

Leodevico Luna Ilag (2 out of 6 patents)

4. Barbara E Power (2 out of 2 patents)

5. Frank Hensel (2 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…